What Do AACI Cancer Centers Do?
The Association of American Cancer Institutes comprises 96 leading cancer research centers in North America. AACI's membership roster includes National Cancer Institute-designated centers and academic-based cancer research programs that receive NCI support.

AACI cancer centers are at the forefront of the national effort to eradicate cancer. They form the United States’ cancer research infrastructure, which is recognized as the best in the world. These centers of excellence work to ease the burden of cancer on patients, families and communities through a comprehensive and multidisciplinary program of research, treatment, patient care, prevention, education and community outreach.

AACI cancer centers are acclaimed worldwide for their excellence in translating promising research findings into new interventions to prevent and treat cancer. Almost every new cancer treatment, key cancer research discovery, or new cancer-related technology available today had its origin as a clinical trial at an AACI cancer center, where it was developed in close partnership with the National Cancer Institute (NCI) and pharmaceutical and biotechnology industries.

How do AACI cancer centers serve their communities?
AACI cancer centers offer their communities ready access to cancer experts from a wide array of disciplines, including diagnosis, treatment, prevention, and patient care. AACI cancer centers also offer access to novel cancer therapies.

What are the benefits of NIH/NCI funding?
With funding from the National Institutes of Health (NIH), AACI cancer centers not only save lives but generate biomedical jobs which boost the economy.  AACI cancer centers contribute to economic development in their regions by joining with partners in the pharmaceutical and biotech industries to create new opportunities to advance the progress against cancer.  AACI urges Congress to provide predictable and sustained support to the NIH in FY 2016 with an appropriation of at least $32 billion, including a commensurate increase for the National Cancer Institute (NCI). A funding level of at least $32 billion is necessary to: (1) ensure that the momentum in scientific discovery achieved over the past few years will continue to yield important advances in patient care, and (2) restore lost purchasing power and mitigate the harmful impact of budget cuts, including cuts in 2013 caused by sequestration that are set to resume in FY 2016 unless Congress acts.